Indian premium skincare label RAS Luxury Skincare has secured $7.5 million (about ₹62–65 crore) in a Series B round led by Dabur Ventures, with participation from existing backers including Unilever Ventures. The fresh capital will fund omnichannel expansion, product R&D and marketing as the brand scales in India’s fast-growing premium beauty segment.
Funding to strengthen omnichannel reach and product innovation
RAS said the funds will accelerate its omnichannel strategy, combining an expanded offline footprint with continued direct-to-consumer (D2C) growth. The company plans to open more exclusive brand outlets (EBOs) in metro centres while sustaining distribution through leading e-commerce and quick-commerce platforms to deepen pan‑India reach.
A portion of the investment will be allocated to research and development, with a focus on botanical science and ingredient research. RAS aims to develop high‑performance, natural formulations tailored to contemporary Indian skin concerns, and to broaden its portfolio of facial oils, serums, cleansers and moisturisers.
The capital will also support stepped‑up marketing efforts, enhanced customer engagement programs and expansion of the leadership team to manage the next phase of growth.
Strategic alignment with Dabur Ventures
Dabur Ventures’ lead role is notable as the investment arm of Dabur, a household name in Ayurveda‑based FMCG. The move reflects a strategic bet on premium, clean and natural beauty brands that leverage botanical and Ayurvedic heritage.
Continued participation by Unilever Ventures and other investors signals sustained confidence in RAS’s business model and growth potential. Beyond capital, these investors bring category expertise, distribution insights and global best practices that could help RAS compete with both domestic and international luxury skincare labels.
Positioning within India’s premium skincare market
Founded by Shubhika, Suramya and Sangeeta Jain, RAS positions itself as a “farm‑to‑face” brand with a vertically integrated supply chain covering sourcing, formulation and manufacturing. This approach supports quality control and traceability—attributes increasingly valued by conscious consumers seeking clean and transparent products.
Despite its relative youth, RAS has reported strong traction driven by premium positioning, aesthetic packaging and a focus on natural actives. The brand is capitalising on a broader industry trend: urban Indian consumers are trading up to effective, clean and well‑designed skincare, fuelling premiumisation across the beauty and personal care market.
Outlook and industry implications
With the new funding, RAS is expected to accelerate store openings, broaden product lines and potentially explore international markets such as the Indian diaspora and global clean‑beauty consumers. The $7.5 million round also underscores growing investor appetite for Indian D2C beauty startups that pair differentiated product platforms with robust distribution strategies.
As competition intensifies, brands that combine scientific R&D, transparent sourcing and omnichannel execution are likely to gain an edge. For RAS Luxury Skincare, the Series B injection aims to convert early momentum into sustained leadership within India’s luxury beauty ecosystem.
